Intelligent Bio Solutions Inc. (INBS) | Stock Price, Analysis, News, Fundaments & Technical Information

stock

Intelligent Bio Solutions Inc.

NASDAQ | INBS

1.45

USD

-0.055 (-3.67%)

AT CLOSE (AS OF Apr 3, 2025)

$6.1M

MARKET CAP

P/E Ratio

-2.3

EPS

52 Week High

52 Week Low

LIFE SCIENCES

Sector

INBS Chart

Area

Trade Smarter

Take control of your trading journey with a set of smart tools for serious trades

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Learn More About Backtests

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Learn More About Scanner

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Learn More About Signals

Journal

Record your trades and performance to improve your trading with AfterPullback’s Trading Journal

Learn More About Journal

INBS Technicals

Tags:

INBS Earnings

Yearly Income Statement (As of Jun 30, 2024)

Field	Value (USD)
Gross Profit	$1.4M
Total Revenue	$3.1M
Cost Of Revenue	$1.7M
Costof Goods And Services Sold	$70K
Operating Income	-$10M
Selling General And Administrative	$9.3M
Research And Development	$1.7M
Operating Expenses	$12M
Investment Income Net	-
Net Interest Income	-$82K
Interest Income	$85K
Interest Expense	$167K
Non Interest Income	$3.1M
Other Non Operating Income	-
Depreciation	$15K
Depreciation And Amortization	$1.2M
Income Before Tax	-$10M
Income Tax Expense	$133K
Interest And Debt Expense	-
Net Income From Continuing Operations	-$10M
Comprehensive Income Net Of Tax	-$10M
Ebit	-$10M
Ebitda	-$9.1M
Net Income	-$10M

Revenue & Profitability

Earnings Performance

INBS Financials

Highlights

Balance Sheet

Cash Flow

Income Statement

Yearly

Quarterly

yearly Balance Sheet (As of Jun 30, 2024)

Field	Value (USD)
Total Assets	$14M
Total Current Assets	$8.5M
Cash And Cash Equivalents At Carrying Value	$6.3M
Cash And Short Term Investments	$6.3M
Inventory	$778K
Current Net Receivables	$453K
Total Non Current Assets	$5.2M
Property Plant Equipment	$566K
Accumulated Depreciation Amortization Ppe	$61K
Intangible Assets	$4.4M
Intangible Assets Excluding Goodwill	$4.4M
Goodwill	-
Investments	-
Long Term Investments	-
Short Term Investments	-
Other Current Assets	$498K
Other Non Current Assets	-
Total Liabilities	$5.6M
Total Current Liabilities	$5.5M
Current Accounts Payable	$602K
Deferred Revenue	$2.5M
Current Debt	$515K
Short Term Debt	$1.1M
Total Non Current Liabilities	$81K
Capital Lease Obligations	$356K
Long Term Debt	$515K
Current Long Term Debt	$515K
Long Term Debt Noncurrent	-
Short Long Term Debt Total	$515K
Other Current Liabilities	$1.2M
Other Non Current Liabilities	-
Total Shareholder Equity	$8.3M
Treasury Stock	$1
Retained Earnings	-$52M
Common Stock	$35K
Common Stock Shares Outstanding	$3.5M

yearly Cash Flow (As of Jun 30, 2024)

Field	Value (USD)
Operating Cashflow	-$9.6M
Payments For Operating Activities	-
Proceeds From Operating Activities	-
Change In Operating Liabilities	-$946K
Change In Operating Assets	-$122K
Depreciation Depletion And Amortization	$974K
Capital Expenditures	$5.4K
Change In Receivables	$136K
Change In Inventory	-$202K
Profit Loss	-$10M
Cashflow From Investment	-$221K
Cashflow From Financing	$15M
Proceeds From Repayments Of Short Term Debt	-
Payments For Repurchase Of Common Stock	-
Payments For Repurchase Of Equity	-
Payments For Repurchase Of Preferred Stock	-
Dividend Payout	-
Dividend Payout Common Stock	-
Dividend Payout Preferred Stock	-
Proceeds From Issuance Of Common Stock	-
Proceeds From Issuance Of Long Term Debt And Capital Securities Net	-
Proceeds From Issuance Of Preferred Stock	-
Proceeds From Repurchase Of Equity	$11M
Proceeds From Sale Of Treasury Stock	-
Change In Cash And Cash Equivalents	-
Change In Exchange Rate	-
Net Income	-$10M

yearly Income Statement (As of Jun 30, 2024)

Field	Value (USD)
Gross Profit	$1.4M
Total Revenue	$3.1M
Cost Of Revenue	$1.7M
Costof Goods And Services Sold	$70K
Operating Income	-$10M
Selling General And Administrative	$9.3M
Research And Development	$1.7M
Operating Expenses	$12M
Investment Income Net	-
Net Interest Income	-$82K
Interest Income	$85K
Interest Expense	$167K
Non Interest Income	$3.1M
Other Non Operating Income	-
Depreciation	$15K
Depreciation And Amortization	$1.2M
Income Before Tax	-$10M
Income Tax Expense	$133K
Interest And Debt Expense	-
Net Income From Continuing Operations	-$10M
Comprehensive Income Net Of Tax	-$10M
Ebit	-$10M
Ebitda	-$9.1M
Net Income	-$10M

INBS Profile

Intelligent Bio Solutions Inc. Profile

Sector: LIFE SCIENCES

Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

None

Most Active

Symbol	Price	Change %	Market Cap	Volume
DMN	$0.02	13.04%	-	706,860,781
NVDA	$103.14	-6.59%	$2.68T	263,349,217
LCID	$2.34	-2.30%	$7.67B	187,389,814
F	$9.68	-4.68%	$39.53B	173,285,336
PTIX	$0.43	91.50%	$4.04M	173,208,693

See more →

Symbol	Price	Change %	Market Cap	Volume
JNJ	$160.56	3.35%	$399.65B	9,908,361
PG	$172.76	1.92%	$399.61B	6,083,153
NVO	$67.60	-0.95%	$308.32B	7,033,051
AZN	$74.03	2.50%	$225.70B	6,150,517
MRK	$86.76	0.18%	$220.07B	7,844,359

See more →

Top Gainers

Symbol	Price	Change %	Market Cap	Volume
VCIG	$6.06	1,818.33%	$26.40M	302,396
MKTW	$9.20	1,686.75%	$19.91M	106,995
ICCT	$4.38	111.59%	$9.78M	168,784,937
PTIX	$0.43	91.50%	$4.04M	173,208,693
MRM	$0.65	74.84%	$2.91M	51,693,935

See more →

Top Losers

Symbol	Price	Change %	Market Cap	Volume
ALDX	$1.42	-73.33%	$326.91M	20,249,631
RFAC	$2.70	-68.60%	$8.44M	605,339
PKBO	$0.02	-67.86%	$531.87K	66,140
TCBP	$0.50	-67.53%	$360.37K	1,955,586
OMQS	$0.04	-66.36%	$1.50M	950,669